This research report presents an in-depth analysis of the global market for biopsy devices, segmented by product type, imaging technique, application, end user and geographic markets. It discusses key devices (vacuum-assisted biopsy [VAB] devices, fine needle aspiration biopsy [FNAB] devices, core needle biopsy [CNB] devices, biopsy guidance systems, biopsy needles, biopsy forceps and others). Applications include trends and market estimates of key application areas (breast cancer, gastrointestinal cancer, lung cancer, liver cancer, prostate cancer and cervical cancer, among others). This report focuses on key imaging technologies used in the process of performing biopsies (ultrasound, magnetic resonance imaging [MRI], computed tomography [CT] and others). The report also reviews the supply chain from manufacturers to surgeons.
The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.
Report Includes
44 data tables and 21 additional tables
Detailed overview and an up-to-date analysis of the global market for biopsy devices
Analyses of the global market trends, with revenue data (sales figures) for 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
Estimation of the actual market size and revenue forecast for the global biopsy devices market, and corresponding market share analysis by device type, therapeutic area/application, image guiding technology, end user, and region
Identification of the viable technology drivers and barriers through a holistic review of various next generation imaging technologies used in the process of performing biopsies and their key therapeutic areas in the cancer diagnostics market
Review of cancer statistics and epidemiology insights and SWOT analysis of various cancer biotherapeutics present in the market
A look at major issues and trends with relate to the R&D of more effective cancer treatment, and new cancer therapeutics in development, and outlook on cancer clinical trials
Assessment of the market growth opportunities, SWOT analysis of the leading companies engaged in manufacturing and development of biopsy devices, emerging trends and technology developments, along with the COVID-19 implications on the marketplace
Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
Patent grants and patent applications on biopsy devices and cancer diagnostics industry
Descriptive company profiles of the leading market players, including Argon Medical Devices Inc., Boston Scientific Corp., FujiFilm Holdings Corp., Mammotome, and Olympus Corp.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives 1.2 Reasons for Doing this Study 1.3 Scope of Report 1.4 What's New in this Update? 1.5 Methodology and Information Sources 1.5.1 Primary Data and Information Gathering 1.5.2 Secondary Data and Information Gathering 1.5.3 Market Share Analysis and Market Forecast Prediction 1.6 Geographic Breakdown 1.7 Analyst's Credentials 1.8 Custom Research 1.9 Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview of Biopsy Devices
3.1 Biopsy 3.2 Types of Biopsies 3.2.1 Bone Marrow Aspiration and Biopsy 3.2.2 Core Biopsy 3.2.3 Endometrial Biopsy 3.2.4 Endoscopic Biopsy 3.2.5 Excisional Biopsy and Incisional Biopsy 3.2.6 Fine-Needle Aspiration (Fna) Biopsy 3.2.7 Sentinel Lymph Node Biopsy 3.2.8 Skin Biopsy 3.2.9 Shave Biopsy 3.2.10 Punch Biopsy 3.3 Biopsy Devices 3.4 Regulation of Biopsy Devices 3.4.1 U.S. Regulation of Biopsy Devices 3.4.2 Eu Regulation of Biopsy Devices 3.4.3 Reimbursement Policies 3.5 Market Dynamics 3.5.1 Market Drivers 3.5.2 Market Restraints 3.5.3 Market Opportunities 3.5.4 Cancer Diagnostics and Imaging
12.1 Global Company Ranking 12.1.1 Other Key Players 12.1.2 Recent News
Chapter 13 Company Profiles
Argon Medical Devices Inc.
B. Braun Melsungen AG
Becton, Dickinson and Co. (Carefusion Corp.)
Boston Scientific Corp.
Cardinal Health Inc.
Conmed Corp.
Cook Medical Inc.
Dtr Medical Ltd.
Danaher Corp. (Mammotome)
Fujifilm Holdings Corp.
Hologic Inc.
Inrad Inc.
Merit Medical Systems Inc.
Mdna Life Sciences Inc.
Mauna Kea Technologies
Medtronic
Mdxhealth Inc.
Olympus Corp.
Chapter 14 Appendix A: Company Addresses and Contact Details
14.1 Company Address and Contact Details
Chapter 15 Appendix B: Abbreviations
List of Tables
Summary Table: Global Market for Biopsy Devices, by Region, Through 2027 Table 1: Implementation of Breast Cancer Screening Programs, by Country Table 2: Cancer Deaths, 2020 Table 3: No. People 65+, by Region, 2019 and 2050 Table 4: Global Market for Biopsy Devices, by Product Type, Through 2027 Table 5: Global Market for Biopsy Guidance Systems, by Region, Through 2027 Table 6: Global Market for Needle-Based Biopsy Guns, by Region, Through 2027 Table 7: Global Market for Needle-Based Biopsy Guns, by Product Type, Through 2027 Table 8: Global Market for Core Needle Biopsy (CNB), by Region, Through 2027 Table 9: Global Market for Fine Needle Aspiration Biopsy (FNAB), by Region, Through 2027 Table 10: Global Market for Vacuum-Assisted Biopsy (VAB), by Region, Through 2027 Table 11: Global Market for Biopsy Needles, by Region, Through 2027 Table 12: Global Market for Biopsy Forceps, by Region, Through 2027 Table 13: Global Market for Other Biopsy Devices, by Region, Through 2027 Table 14: Global Market for Biopsy Devices, by Imaging Guiding Technology Type, Through 2027 Table 15: Global Market for MRI-Guided Biopsy Devices, by Region, Through 2027 Table 16: Global Market for Stereotactic Guided Biopsy Devices, by Region, Through 2027 Table 17: Global Market for Ultrasound Guided Biopsy Devices, by Region, Through 2027 Table 18: Global Market for CT-Guided Biopsy Devices, by Region, Through 2027 Table 19: Global Market for Other Biopsy Imaging Devices, by Region, Through 2027 Table 20: Global Market for Biopsy Devices, by Application, Through 2027 Table 21: Global Market for Breast Biopsy Devices, by Region, Through 2027 Table 22: Global Market for GI Biopsy Devices, by Region, Through 2027 Table 23: Global Market for Prostate Biopsy Devices, by Region, Through 2027 Table 24: Global Market for Liver Biopsy Devices, by Region, Through 2027 Table 25: Global Market for Lung Biopsy Devices, by Region, Through 2027 Table 26: Global Market for Kidney Biopsy Devices, by Region, Through 2027 Table 27: Global Market for Gynecological Biopsy Devices, by Region, Through 2027 Table 28: Global Market for Other Application of Biopsy Devices, by Region, Through 2027 Table 29: Global Market for Biopsy Devices, by End User, Through 2027 Table 30: Global Market for Biopsy Devices in Diagnostic Labs, by Region, Through 2027 Table 31: Global Market for Biopsy Devices Used in Hospitals, by Region, Through 2027 Table 32: Global Market for Biopsy Devices, by Region, Through 2027 Table 33: North American Market for Biopsy Devices, by Country, Through 2027 Table 34: European Market for Biopsy Devices, by Country, Through 2027 Table 35: Asia-Pacific Market for Biopsy Devices, by Country, Through 2027 Table 36: RoW Market for Biopsy Devices, Through 2027 Table 37: U.S. Biopsy Device Patents, by Company, 2022-2023 Table 38: European Biopsy Device Patents, by Company, 2022 Table 39: Japanese Biopsy Device Patents, by Company, 2021-2022 Table 40: Chinese Biopsy Device Patents, by Company, 2022 Table 41: Japanese Biopsy Device Patents, by Company, 2021-2022 Table 42: Global Market Rankings for Biopsy Devices, by Manufacturer, 2021 Table 43: Argon Medical Devices Inc.: Product Portfolio Table 44: B. Braun Melsungen AG: Products Table 45: Becton, Dickinson and Co.: Financials, 2021 Table 46: Boston Scientific Corp.: Product Portfolio Table 47: Boston Scientific Corp.: Recent Financial Performance, 2019-2021 Table 48: Cardinal Health Inc.: Product Portfolio Table 49: Cardinal Health Inc.: Recent Financial Performance, 2019-2021 Table 50: Conmed Corp.: Product Portfolio Table 51: Conmed Corp.: Recent Financial Performance, 2019-2021 Table 52: Cook Medical Inc.: Product Portfolio Table 53: Mammotome: Product Portfolio Table 54: FujiFilm Holdings Corp.: Recent Financials, 2019-2021 Table 55: Hologic Inc.: Product Portfolio Table 56: Hologic Inc.: Financials, 2021 Table 57: INRAD Inc.: Product Portfolio Table 58: Merit Medical Systems: Product Portfolio Table 59: Merit Medical Systems: Recent Financials, 2019-2021 Table 60: Medtronic: Product Portfolio Table 61: Medtronic: Financials, 2019-2022 Table 62: Olympus Corp.: Recent Financials, 2019-2021 Table 63: Company Address and Contact Details Table 64: Abbreviations
List of Figures
Summary Figure A: Global Market for Biopsy Devices, by Region, 2019-2027 Summary Figure B: Global Market Shares for Biopsy Devices, by Region, 2021 Figure 1: Global Market for Biopsy Devices, by Product Type, 2019-2027 Figure 2: Global Market Shares for Biopsy Devices, by Product Type, 2021 Figure 3: Global Market for Biopsy Guidance Systems, by Region, 2019-2027 Figure 4: Global Market Shares for Biopsy Guidance Systems, by Region, 2021 Figure 5: Global Market for Needle-Based Biopsy Guns, by Product Type, 2019-2027 Figure 6: Global Market Shares for Needle-Based Biopsy Guns, by Region, 2021 Figure 7: Global Market for Needle-Based Biopsy Guns, by Product Type, 2019-2027 Figure 8: Global Market Shares for Needle-Based Biopsy Guns, by Product Type, 2021 Figure 9: Global Market for Biopsy Needles, by Region, 2019-2027 Figure 10: Global Market Shares for Biopsy Needles, by Region, 2021 Figure 11: Global Market for Biopsy Forceps, by Region, 2019-2027 Figure 12: Global Market Shares for Biopsy Forceps, by Region, 2021 Figure 13: Global Market for Other Biopsy Devices, by Region, 2019-2027 Figure 14: Global Market Shares for Other Biopsy Devices, by Region, 2021 Figure 15: Global Market for Biopsy Devices, by Imaging Guiding Technology Type, 2019-2027 Figure 16: Global Market Shares for Biopsy Devices, by Imaging Guiding Technology Type, 2021 Figure 17: Global Market for Biopsy Devices, by Application, 2019-2027 Figure 18: Global Market Shares for Biopsy Devices, by Application, 2021Global Market Shares for Biopsy Devices, by Application, 2021 Figure 19: Global Market for Biopsy Devices, by End User, 2019-2027 Figure 20: Global Market Shares for Biopsy Devices, by End User, 2021 Figure 21: Global Market for Biopsy Devices, by Region, 2019-2027 Figure 22: Global Market Shares for Biopsy Devices, by Region, 2021 Figure 23: North American Market Shares for Biopsy Devices, by Country, 2021 Figure 24: European Market Shares for Biopsy Devices, by Country, 2021 Figure 25: Asia-Pacific Market Shares for Biopsy Devices, by Country, 2021 Figure 26: B. Braun Melsungen AG: Revenue, 2019-2021 Figure 27: B. Braun Melsungen AG: Revenue Share, by Country/Region, 2021 Figure 28: B. Braun Melsungen AG: Revenue Share, by Segment, 2021 Figure 29: Becton, Dickinson and Co.: Revenue Share, by Business Unit, 2021 Figure 30: Becton, Dickinson and Co.: Revenue Share, by Country/Region, 2021 Figure 31: Boston Scientific Corp.: Revenue Share, by Product Segment, 2021 Figure 32: Cardinal Health Inc.: Revenue Share, by Segment, 2021 Figure 33: Conmed Corp.: Revenue Share, by Segment, 2021 Figure 34: FujiFilm Holdings Corp.: Revenue Share, by Segment, 2021 Figure 35: FujiFilm Holdings Corp.: Revenue Share, by Country/Region, 2021 Figure 36: Hologic Inc.: Financials, 2019-2022 Figure 37: Hologic Inc.: Revenue Share, by Country/Region, 2021 Figure 38: Hologic Inc.: Revenue Share, by Segment, 2021 Figure 39: Merit Medical Systems: Revenue Share, by Business Segment, 2021 Figure 40: Medtronic: Revenue Share, by Key Disease Segment, 2022 Figure 41: Olympus Corp.: Revenue Share, by Business Segment, 2021
Executive Summary
A biopsy is the process of sample collection to identify the presence of disease-causing agents in a particular organ. Several types of biopsy products are available (biopsy guidance systems, needle-based biopsy guns, biopsy needles, biopsy forceps and others [brushes, curettes, punches]).
The global market for biopsy devices was valued at approximately $2.1 billion in 2021 and is expected to generate revenue of around $2.2 billion by 2022, increasing at a compound annual growth rate (CAGR) of 6.8% from 2022 through 2027. The global market for biopsy devices is currently dominated by biopsy guidance systems. The increased prevalence of chronic disease and a rise in income levels in developing economies are promoting the growth of novel biopsy procedures. Increased awareness of diagnostic methods for chronic diseases (breast cancer, lung cancer) are also increasing the demand for integrated biopsy technologies (e.g., MRI-guided breast biopsy).
The global market for biopsy devices is segmented into product type, imaging guiding technique, application, end user and geography. Imaging guiding techniques include MRI-guided breast biopsy, stereotactic-guided breast biopsy, ultrasound-guided breast biopsy, CT scan and other technologies such as X-ray and sonography. Advancements in imaging technology have increased the demand and commercial application for biopsy devices. Medical device manufacturing companies are concentrating on launching novel biopsies. For instance, Izi Medical Products launched a quick-core auto biopsy system for soft tissue biopsies. It is a lightweight, fully automatic biopsy device that builds upon the company’s previous semi-automatic biopsy system.
The global market for biopsy devices includes product type segments: biopsy guidance systems, needle-based biopsy guns, biopsy needles, biopsy forceps and others (brushes, curettes, punches). Application segments include kidney, lung, breast, gastrointestinal, prostate, liver and gynecological biopsy techniques. This market is dominated by breast cancer biopsy with higher prevalence of the disease and availability of efficient treatment. Applications of breast cancer biopsy devices are expected to increase from about $723.0 million in 2021 to around $1.1 billion by the end of 2027 after increasing at a CAGR of 6.9%. Applications of other biopsy devices represent the smallest share of the market by application and are expected to increase from $86.8 million in 2021 to $120.0 million through 2027, growing at a CAGR of 5.0%.
Breast biopsy, GI biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy and other biopsies are the categories of application. The regional markets analyzed are North America, Europe, Asia-Pacific and the Rest of the World (RoW).
MRI-guided biopsy, CT-guided biopsy, Ultrasound-guided biopsy, stereotactic-guided biopsy and other guidance techniques are the imaging guiding techniques.
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
